ALNY: Alnylam Pharmaceuticals Inc

319.07 USD 6.55 (2.01%)

Secteur: Soins de Santé Base: US Dollar Devise de profit: US Dollar

Le taux de change de ALNY a changé de -2.01% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 317.88 et à un maximum de 325.62.

Suivez la dynamique Alnylam Pharmaceuticals Inc. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.

Graphique en Plein Ecran

ALNY Nouvelles

Investing 13:16 Alnylam Pharmaceuticals stock price target raised to $290 by Cantor Fitzgerald
Investing 12:06 JPMorgan raises Alnylam Pharmaceuticals stock price target on Amvuttra forecast
Seeking Alpha 15:53 Parnassus Mid Cap Growth Fund Q2 2025 Commentary
Investing 14:51 Jefferies reiterates Buy rating on Alnylam Pharmaceuticals stock, citing strong Amvuttra sales
Investing 11:15 Goldman rolls out latest U.S. Conviction List update
Investing 14:05 Alnylam Pharmaceuticals stock hits all-time high at 326.12 USD
Seeking Alpha 14:30 Thrivent Mid Cap Growth Fund Q1 2025 Commentary
Benzinga 13:11 Tesla To Rally Around 45%? Here Are 10 Top Analyst Forecasts For Thursday - Apple (NASDAQ:AAPL), Alnylam Pharmaceuticals (NASDAQ:ALNY)
Investing 12:01 Needham raises Alnylam price target on bullish Amvuttra outlook
Investing 10:02 Alnylam price target raised to $360 at BMO on strong Amvuttra sales
Investing 14:09 Alnylam appoints Pushkal Garg as chief research and development officer
Investing 13:46 Alnylam Pharmaceuticals stock hits all-time high at $311.24
Investing 13:47 Alnylam stock poised for strong quarter as Amvuttra launch gains traction
Investing 11:05 John Maraganore joins Axion Bio board to advance cancer therapy
Seeking Alpha 11:20 American Century Focused Dynamic Growth Fund Q1 2025 Commentary
Investing 14:08 Alnylam at Goldman Sachs Healthcare Conference: Strategic Growth Insights
Investing 10:09 EC approves first RNAi therapy for ATTR cardiomyopathy
Benzinga 15:59 Moderna Beats Alnylam Appeal In COVID Vaccine Patent Case - Alnylam Pharmaceuticals (NASDAQ:ALNY), Moderna (NASDAQ:MRNA)
Seeking Alpha 07:34 BridgeBio: New Data Bolsters The Bull Case (NASDAQ:BBIO)
Investing 11:34 H.C. Wainwright reaffirms Alnylam stock price target at $500
Investing 18:38 Alnylam stock soars to all-time high of $304.52
Investing 14:15 RBC Capital maintains $330 target on Alnylam Pharmaceuticals stock
Seeking Alpha 21:45 Arrowhead Pharmaceuticals: A Reluctant Sell Rating Explained (Rating Downgrade) (ARWR)
Seeking Alpha 18:25 Intellia: Heart Disease Safety Setback Triggers Selloff - Caution Advised (NASDAQ:NTLA)

Range quotidien

317.88 325.62

Range Annuel

205.87 333.70

Clôture Précédente: 324.69
Ouverture: 325.62

Bid: 319.07
Ask: 319.37

Plus Bas: 317.88
Plus Haut: 325.62

Volume: 863

Changement quotidien: -2.01%
Changement Mensuel: -1.80%

Changement à 6 Mois: 18.76%
Changement Annuel: 26.96%

18 juillet, vendredi